Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

JPMorgan Chase & Co (NY:JPM)

263.01 +2.96 (+1.14%)
Official Closing Price Updated: 7:00 PM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about JPMorgan Chase & Co

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
JPMorgan Chase Unusual Options Activity For January 08
Via Benzinga
Jamie Dimon Questioned Bitcoin's 21 Million Cap Years Before BlackRock — Here's How Much You'd Have If You Invested $1,000 Into BTC When JPMorgan CEO Shared His Take
The world’s largest asset manager, BlackRock, kicked up a storm last month after supposedly disputing Bitcoin's (CRYPTO: BTC) supply cap in one of its explai 
Via Benzinga
Warren Buffett's Warning to Investors Is Hard to Ignore
Via The Motley Fool
Yield Curve Normalization, Cheap Valuation, EPS Growth To Boost Banks In 2025: Truist Initiates Coverage On These 14 Regional Names
Truist Securities initiated coverage on 24 stocks anticipating earnings and loan growth, steeper yield curve, and ample capital for expansion. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Market Whales and Their Recent Bets on JPM Options
Via Benzinga
Acquisition of Kadima Neuropsychiatry Institute for CNS & Psychedelic Research Planned; New Drug Application for Suicidal Depression Treatment: $NRXP
NRx Pharmaceuticals, Inc.: Stock Symbol: NRXP IS Aiming to be the First FDA-Approved Medication to Treat Suicidal DepressionMIAMI - Jan. 2, 2025 - PRLog -- Developing NRX-101, an FDA-Designated... 
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Spotlight on JPMorgan Chase: Analyzing the Surge in Options Activity
Via Benzinga
JPMorgan Sees Marvell's AI Revenue Surge With $2 Billion Run-Rate In Networking by 2025
The JPMorgan analyst shared Marvell Technology is on track to exceed its AI target of $2.5B by 2025, with strong performance in optical/copper networking and partnerships with Amazon. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Excelerate Energy Lags Peers Amid Risks Of Operating In Developing Countries: Analyst Downgrades
JP Morgan downgrades Excelerate Energy to Underweight, citing flat EBITDA growth, emerging market risks, and slower IPO growth. 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
10 Financials Stocks Whale Activity In Today's Session
Via Benzinga
This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Robinhood Stock Draws Attention After JPMorgan Upgrade, Price Target Hike: Retail Enthusiasm Soars
According to TheFly, JPMorgan highlighted that Robinhood has "made notable progress in legitimizing its operations" compared to its primary reliance on meme-stock trading three years ago. 
Via Stocktwits
JPMorganChase Survey: Businesses Ring in the New Year with Renewed Optimism
From JPMorgan Chase & Co.
Via Business Wire
Why Teradyne (TER) Stock Is Up Today
Shares of semiconductor testing company Teradyne (NASDAQ:TER) jumped 7.2% in the afternoon session after Northland analysts upgraded the stock's rating from Market Perform (Hold) to Outperform (Buy)... 
Via StockStory
Optimum-MSGN Standoff Could Pressure MSG Networks' Finances: Analyst
JP Morgan analyst David Karnovsky shared views on the impact of the Optimum-MSGN carriage battle on Sphere Entertainment and Madison Square Garden Sports. 
Via Benzinga
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights. 
Via Benzinga
JPMorgan Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Via Benzinga
Alphabet Drives Into 2025: Google's AI, Waymo Lead The Charge
Wall Street anticipates Alphabet's Google to continue its innovation streak in 2025, with key growth drivers including generative AI and autonomous driving. JPMorgan analyst reiterates Overweight... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025
ATLANTA, GA - January 6, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced... 
Via TheNewswire.com
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Engage Investors and Partners at Key January Conferences
Via Investor Brand Network
Here's How Trump Could Wipe Out 40% of Tesla's Profits After Taking Office, According To JPMorgan Analyst
The profitability of Tesla Inc. could be severely impacted under the second Trump administration, with a potential 40% decrease. 
Via Benzinga
Topics Government
Exposures Political
3 ETFs I'm Buying in January 2025
Via The Motley Fool
Topics ETFs
A Mass Exodus Of Big Banks From The Net-Zero Bank Climate Alliance
Citigroup, BofA, and Morgan Stanley join Vanguard, JPMorgan, BlackRock, State Street, Goldman Sachs and Wells Fargo in leaving. 
Via Talk Markets
Q4 Earnings Season Looms: A Preview
The expectation is that 2024 Q4 earnings for the S&P 500 index will be up +7.6% on +4.7% higher revenues. 
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
3 Top Value Stocks to Buy in January
This year could look dramatically different than the past few have. Start it on the right foot with these three underestimated prospects. 
Via The Motley Fool
Ranked: The World’s Top Companies By Revenue In 2024
Today, U.S. retail giants are the largest companies by revenue globally thanks to their international reach and the strength of the American consumer. 
Via Talk Markets
The question on everyone's mind: Will JPMORGAN CHASE & CO breakout?
The technical analysis for JPMORGAN CHASE & CO (NYSE:JPM) is highly positive, with a rating of 9 out of 10, suggesting a potential breakout. 
Via Chartmill
Under the Radar: New Year, New Financial Frontiers -Beyond the Big Banks
Via Benzinga
3 Stocks Helping to Bring AI to Healthcare
Many profitable companies are using AI to make healthcare more efficient; and these companies are rewarding investors with share price growth and dividends 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.